Brenda Libby Coleman

Array ( [id] => 4432881 [patent_doc_number] => 07897593 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-01 [patent_title] => 'HIV integrase inhibitors' [patent_app_type] => utility [patent_app_number] => 11/754462 [patent_app_country] => US [patent_app_date] => 2007-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30967 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/897/07897593.pdf [firstpage_image] =>[orig_patent_app_number] => 11754462 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13754 [patent_doc_number] => 07807667 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-05 [patent_title] => '1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives and their medical use' [patent_app_type] => utility [patent_app_number] => 12/300060 [patent_app_country] => US [patent_app_date] => 2007-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6264 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/807/07807667.pdf [firstpage_image] =>[orig_patent_app_number] => 12300060 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6515344 [patent_doc_number] => 20100216780 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-26 [patent_title] => 'NOVEL 1,4-DIAZA-BICYCLO[3.2.2]NONYL OXADIAZOLYL DERIVATIVES AND THEIR MEDICAL USE' [patent_app_type] => utility [patent_app_number] => 12/297333 [patent_app_country] => US [patent_app_date] => 2007-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11114 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20100216780.pdf [firstpage_image] =>[orig_patent_app_number] => 12297333 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 577800 [patent_doc_number] => 07456167 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-11-25 [patent_title] => 'Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors' [patent_app_type] => utility [patent_app_number] => 11/753137 [patent_app_country] => US [patent_app_date] => 2007-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18105 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/456/07456167.pdf [firstpage_image] =>[orig_patent_app_number] => 11753137 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4432885 [patent_doc_number] => 07897595 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-01 [patent_title] => 'Pyridoazepine derivatives' [patent_app_type] => utility [patent_app_number] => 11/752683 [patent_app_country] => US [patent_app_date] => 2007-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24286 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/897/07897595.pdf [firstpage_image] =>[orig_patent_app_number] => 11752683 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5534118 [patent_doc_number] => 20090233906 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-17 [patent_title] => 'IMIDAZOAZEPINONE COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/299855 [patent_app_country] => US [patent_app_date] => 2007-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16417 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20090233906.pdf [firstpage_image] =>[orig_patent_app_number] => 12299855 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 318732 [patent_doc_number] => 07521442 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-21 [patent_title] => 'Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors' [patent_app_type] => utility [patent_app_number] => 11/752354 [patent_app_country] => US [patent_app_date] => 2007-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18076 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/521/07521442.pdf [firstpage_image] =>[orig_patent_app_number] => 11752354 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7691234 [patent_doc_number] => 20070232799 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-04 [patent_title] => 'PROCESS FOR PREPARING 6-ARYL-4H-S-TRIAZOLO[3,4-c]-THIENO[2,3-e]-1,4-DIAZEPINES' [patent_app_type] => utility [patent_app_number] => 11/749971 [patent_app_country] => US [patent_app_date] => 2007-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3190 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20070232799.pdf [firstpage_image] =>[orig_patent_app_number] => 11749971 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5279270 [patent_doc_number] => 20090131402 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-21 [patent_title] => 'Fused heterocyclic compound and use thereof' [patent_app_type] => utility [patent_app_number] => 12/227333 [patent_app_country] => US [patent_app_date] => 2007-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 59233 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20090131402.pdf [firstpage_image] =>[orig_patent_app_number] => 12227333 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5028959 [patent_doc_number] => 20070270406 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-22 [patent_title] => 'Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors' [patent_app_type] => utility [patent_app_number] => 11/745090 [patent_app_country] => US [patent_app_date] => 2007-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22261 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20070270406.pdf [firstpage_image] =>[orig_patent_app_number] => 11745090 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5016848 [patent_doc_number] => 20070260057 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-08 [patent_title] => 'METHODS FOR THE PREPARATION OF PYRAZOLE-CONTAINING COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 11/744340 [patent_app_country] => US [patent_app_date] => 2007-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12875 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20070260057.pdf [firstpage_image] =>[orig_patent_app_number] => 11744340 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 577786 [patent_doc_number] => 07456166 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-11-25 [patent_title] => 'Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors' [patent_app_type] => utility [patent_app_number] => 11/743921 [patent_app_country] => US [patent_app_date] => 2007-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29402 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/456/07456166.pdf [firstpage_image] =>[orig_patent_app_number] => 11743921 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13874 [patent_doc_number] => 07803792 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-28 [patent_title] => 'Quaternary ammonium compounds' [patent_app_type] => utility [patent_app_number] => 11/790975 [patent_app_country] => US [patent_app_date] => 2007-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 180092 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/803/07803792.pdf [firstpage_image] =>[orig_patent_app_number] => 11790975 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4541086 [patent_doc_number] => 07875714 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2011-01-25 [patent_title] => 'Processes for preparing certain hexaazaisowurtzitanes and their use in preparing hexanitrohexaazaisowurtzitane' [patent_app_type] => utility [patent_app_number] => 11/789678 [patent_app_country] => US [patent_app_date] => 2007-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 3943 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/875/07875714.pdf [firstpage_image] =>[orig_patent_app_number] => 11789678 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4652188 [patent_doc_number] => 20080039444 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-14 [patent_title] => 'COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 11/736602 [patent_app_country] => US [patent_app_date] => 2007-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 45625 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20080039444.pdf [firstpage_image] =>[orig_patent_app_number] => 11736602 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5247860 [patent_doc_number] => 20070244094 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-18 [patent_title] => 'BENZOAZEPIN-OXY-ACETIC ACID DERIVATIVES AS PPAR-DELTA AGONISTS USED FOR THE INCREASE OF HDL-C, LOWER LDL-C AND LOWER CHOLESTEROL' [patent_app_type] => utility [patent_app_number] => 11/736221 [patent_app_country] => US [patent_app_date] => 2007-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35071 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20070244094.pdf [firstpage_image] =>[orig_patent_app_number] => 11736221 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 142035 [patent_doc_number] => 07687494 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-30 [patent_title] => 'Substituted spirobenzazepines' [patent_app_type] => utility [patent_app_number] => 11/735149 [patent_app_country] => US [patent_app_date] => 2007-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12178 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/687/07687494.pdf [firstpage_image] =>[orig_patent_app_number] => 11735149 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5070210 [patent_doc_number] => 20070191312 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-16 [patent_title] => 'NOVEL HETEROCYCLIC COMPOUNDS, PREPARATION PROCESS AND INTERMEDIATES, AND USE AS MEDICAMENTS, IN PARTICULAR AS BETA-LACTAMASE INHIBITORS AND ANTIBACTERIALS' [patent_app_type] => utility [patent_app_number] => 11/734608 [patent_app_country] => US [patent_app_date] => 2007-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15050 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20070191312.pdf [firstpage_image] =>[orig_patent_app_number] => 11734608 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8642834 [patent_doc_number] => 08367821 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-05 [patent_title] => 'Preparation of eslicarbazepine and related compounds by asymmetric hydrogenation' [patent_app_type] => utility [patent_app_number] => 12/294855 [patent_app_country] => US [patent_app_date] => 2007-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5047 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12294855 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 211555 [patent_doc_number] => 07622461 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-24 [patent_title] => 'Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders' [patent_app_type] => utility [patent_app_number] => 11/733476 [patent_app_country] => US [patent_app_date] => 2007-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32418 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/622/07622461.pdf [firstpage_image] =>[orig_patent_app_number] => 11733476 [rel_patent_id] =>[rel_patent_doc_number] =>)